Dupixent® (dupilumab) is now approved in India for the treatment of adults with moderate-to-severe atopic dermatitis
Dupixent® (dupilumab) is now approved in India for the treatment of adults with moderat…
Dupixent® (dupilumab) is now approved in India for the treatment of adults with moderat…
Takeda pledges support to HAE patients through its ‘Sunrise patient support program’ …
VLCC Institute , with more than 70 institutes in India and Nepal, is a leader in Beaut…